/ 2 items

#RXRX↓

Featured/ APLD/ 02/18/2026 · 4:17 AM

Nvidia Dumps Stakes: Applied Digital, WeRide & Recursion Stocks Slide in After-Hours

Nvidia's latest 13F filing reveals it sold positions in Applied Digital, WeRide, and Recursion Pharmaceuticals in Q4 2025, causing after-hours dips.

RXRX/ 12/17/2025 · 6:32 AM

JPMorgan Turns Bullish on Recursion Pharmaceuticals

JPMorgan upgrades Recursion Pharmaceuticals to Overweight, raises price target to $11, and highlights blockbuster potential for REC-4881 and promising early cancer data.